NO179094C - Fremgangsmåte for fremstilling av et farmasöytisk preparat for påföring på slimhinnen - Google Patents

Fremgangsmåte for fremstilling av et farmasöytisk preparat for påföring på slimhinnen

Info

Publication number
NO179094C
NO179094C NO883468A NO883468A NO179094C NO 179094 C NO179094 C NO 179094C NO 883468 A NO883468 A NO 883468A NO 883468 A NO883468 A NO 883468A NO 179094 C NO179094 C NO 179094C
Authority
NO
Norway
Prior art keywords
denotes
amino acid
mucosa
preparing
application
Prior art date
Application number
NO883468A
Other languages
English (en)
Norwegian (no)
Other versions
NO179094B (no
NO883468L (no
NO883468D0 (no
Inventor
Jurgen Kurt Sandow
Rainer Schmiedel
Klaus Wirth
Hans Peter Merkle
Susanne Raechs
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO883468D0 publication Critical patent/NO883468D0/no
Publication of NO883468L publication Critical patent/NO883468L/no
Publication of NO179094B publication Critical patent/NO179094B/no
Publication of NO179094C publication Critical patent/NO179094C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO883468A 1987-08-07 1988-08-04 Fremgangsmåte for fremstilling av et farmasöytisk preparat for påföring på slimhinnen NO179094C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873726324 DE3726324A1 (de) 1987-08-07 1987-08-07 Cyclopeptide als resorptionsfoerderer bei applikation auf die schleimhaeute

Publications (4)

Publication Number Publication Date
NO883468D0 NO883468D0 (no) 1988-08-04
NO883468L NO883468L (no) 1989-02-08
NO179094B NO179094B (no) 1996-04-29
NO179094C true NO179094C (no) 1996-08-07

Family

ID=6333298

Family Applications (1)

Application Number Title Priority Date Filing Date
NO883468A NO179094C (no) 1987-08-07 1988-08-04 Fremgangsmåte for fremstilling av et farmasöytisk preparat for påföring på slimhinnen

Country Status (19)

Country Link
US (1) US5091365A (da)
EP (1) EP0302466B1 (da)
JP (1) JP2764930B2 (da)
KR (1) KR970004039B1 (da)
AT (1) ATE69556T1 (da)
AU (1) AU608878B2 (da)
CA (1) CA1331131C (da)
DE (2) DE3726324A1 (da)
DK (1) DK168273B1 (da)
ES (1) ES2038725T3 (da)
FI (1) FI883643A7 (da)
GR (1) GR3003733T3 (da)
HU (1) HU199301B (da)
IE (1) IE60871B1 (da)
IL (1) IL87362A0 (da)
NO (1) NO179094C (da)
NZ (1) NZ225715A (da)
PT (1) PT88192B (da)
ZA (1) ZA885724B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW274552B (da) * 1992-05-26 1996-04-21 Hoechst Ag
EP0710243B1 (en) * 1993-06-29 2000-06-14 Ferring B.V. Synthesis of cyclic peptides
US5767068A (en) * 1997-02-13 1998-06-16 Pathogenesis Corporation Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections
IT1294191B1 (it) * 1997-09-05 1999-03-22 Alfa Wassermann Spa Composizioni farmaceutiche contenenti calcitonina in un dosatore spray per somministrazione intranasale.
KR100611559B1 (ko) * 1998-05-08 2007-04-25 동아제약주식회사 칼시토닌을 함유한 비강투여용 약제학적 조성물
SE514606C2 (sv) * 1998-08-26 2001-03-19 Laekartjaenster I Vaestsverige Läkemedel innehållande GnRH-analoger för behandling av schizofreni
DE10014007A1 (de) * 2000-03-22 2001-10-11 Strathmann Ag & Co Neue Darreichungsformen für DSIP
US20020141970A1 (en) * 2001-03-05 2002-10-03 Pettit Dean K. Stable aqueous solutions of granulocyte macrophage colony-stimulating factor
US7812120B2 (en) 2003-03-21 2010-10-12 Par Pharmaceutical, Inc. Nasal calcitonin formulations containing chlorobutanol
MX2018012716A (es) 2016-04-19 2019-02-11 Griffon Pharmaceuticals Inc Peptidos bioactivos pegilados y usos de los mismos.
CN113874045B (zh) * 2019-03-25 2023-11-24 国立大学法人筑波大学 细胞层渗透促进剂、药剂吸收辅助用组合物及药物组合物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0037943B1 (en) * 1980-03-31 1985-08-14 Teijin Limited Pharmaceutical composition for intrarectal administration, and suppository prepared therefrom
US4900730A (en) * 1981-01-14 1990-02-13 Toyo Jozo Co., Ltd. Preparation which promotes the absorption of peptides
JPS58140026A (ja) * 1982-01-14 1983-08-19 Toyo Jozo Co Ltd 吸収性良好な製剤
FR2509175B1 (fr) * 1981-03-06 1987-01-16 Toyo Jozo Kk Preparation therapeutique ayant d'excellentes proprietes d'absorption
US4568665A (en) 1982-06-25 1986-02-04 Mitchell David C Protein compounds
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
CA1249968A (en) * 1984-04-05 1989-02-14 Kazuo Kigasawa Ointment base
US4537772A (en) * 1984-05-02 1985-08-27 Merck & Co., Inc. Enhancing absorption of drugs from gastrointestinal tract using acylcarnitines
JPS6160620A (ja) * 1984-09-03 1986-03-28 Teijin Ltd ピログルタミン酸エステル類を含有する医薬品組成物
DE3532074A1 (de) * 1985-09-09 1987-03-12 Berlin Chemie Veb Resorptionsvermittler fuer biologisch aktive peptide

Also Published As

Publication number Publication date
HU199301B (en) 1990-02-28
IE882408L (en) 1989-02-07
JPS6466128A (en) 1989-03-13
PT88192B (pt) 1995-03-01
DE3726324A1 (de) 1989-02-16
NO179094B (no) 1996-04-29
JP2764930B2 (ja) 1998-06-11
KR970004039B1 (ko) 1997-03-24
IL87362A0 (en) 1989-01-31
EP0302466B1 (de) 1991-11-21
DE3866307D1 (de) 1992-01-02
EP0302466A1 (de) 1989-02-08
KR890003409A (ko) 1989-04-14
CA1331131C (en) 1994-08-02
FI883643A0 (fi) 1988-08-04
GR3003733T3 (da) 1993-03-16
IE60871B1 (en) 1994-08-24
NZ225715A (en) 1991-02-26
ATE69556T1 (de) 1991-12-15
ES2038725T3 (es) 1993-08-01
NO883468L (no) 1989-02-08
DK168273B1 (da) 1994-03-07
FI883643A7 (fi) 1989-02-08
DK440888A (da) 1989-02-08
US5091365A (en) 1992-02-25
AU608878B2 (en) 1991-04-18
ZA885724B (en) 1989-04-26
AU2043388A (en) 1989-04-20
HUT47599A (en) 1989-03-28
DK440888D0 (da) 1988-08-05
NO883468D0 (no) 1988-08-04
PT88192A (pt) 1989-06-30

Similar Documents

Publication Publication Date Title
FI883249A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 3-desmetyylimevalonihappojohdannaisten valmistamiseksi
EE05191B1 (et) Farmatseutiline kompositsioon, mis sisaldab tolterodiini, ja selle kasutamine
EE04800B1 (et) Oraalne manustamisvorm happes ebapüsiva toimeainetarbeks, toimeaineühik, selle valmistamismeetod ja kasutamine ning meetod oraalse manustamisvormi valmistamiseks
SE8300736D0 (sv) Novel pharmacologically active compounds
DE69212879D1 (de) Magensaftstabile pharmazeutische Formulierungen zur Oral Verbreichung von Gallensäuren
EA200001125A1 (ru) Гелеобразные фармацевтические композиции
ES520226A0 (es) Procedimiento para la preparacion de derivados de cefem.
RU94045950A (ru) Фармацевтический препарат и способ его приготовления
ES2084579T3 (es) Uso de buspirona en la preparacion de una composicion farmaceutica para el tratamiento del abuso del alcohol.
NO903911D0 (no) Fremgangsmaate for fremstilling av 4-hydroksytetrahydropyran-2-on og de tilsvarende dihydroksykarboksylsyrederivater, salter og estere, deres anvendelse som legemidler, farmasoeytiske preparater og forprodukter.
WO1996024370B1 (en) Pharmaceutical non inorganic saline solutions for endonasal administration of a calcitonin
AU2043388A (en) Cyclic peptides as promoters of absorption on administration onto the mucosa
EP0571921A3 (da)
ATE110723T1 (de) Verbindungen mit magensäureinhibitorwirkung und verfahren zur herstellung.
FI941399A0 (fi) Sparfloksasiiniliuos, sen valmistus ja sitä sisältävä suola
ES525441A0 (es) Procedimiento para preparar derivados de acidos isoquinolein-4-carboxilicos
FI963440L (fi) Uudet aminohappojohdannaiset, näiden valmistusmenetelmä ja näitä yhdisteitä sisältävät farmaseuttiset seokset
NO810480L (no) Anologifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater
AU610173B2 (en) New spiro (4,5) decane derivatives, process for the preparation thereof, and pharmaceutical compositions containing them
SE8402199L (sv) Farmaceutiskt preparat innehallande co-dergocrin och en kalciumantagonist
ES519605A0 (es) Procedimiento para la preparacion de nuevas piridobenzodiazepinonas.
AU4831279A (en) New compounds
SE8603517D0 (sv) Heterocyclic compounds and their preparation and pharmaceutical formulation
DE59002790D1 (de) Verfahren zur Herstellung einer Galenischen Zubereitung mit optimaler Bioverfügbarkeit des Wirkstoffs 2-Hydroxy-5-methyllaurophenonoxime (HMLO).
IT8321031A0 (it) Loro derivati, aventi attivita'sali di calcio di amminoacidi o di terapeutica, procedimento per laloro preparazione e composizioni farmaceutiche che li contengono.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN FEBRUARY 2002